What the bacteria in your mouth may reveal about your cancer risk The types of bacteria in your mouth may be linked to your risk of certain cancers.
Community mourns Army veteran's son whose bucket list went viral The life of 10-year-old Ayden Zeigler-Kohler was celebrated Saturday, as family and friends gathered to remember the boy whose eight-month battle with brain cancer was followed by thousands after his Army veteran father shared his bucket list online.
Dad is diagnosed with breast cancer for third time A dad-of-two who made history when he fought to receive a breast cancer drug only available to women is now battling the disease for a third time – despite having a mastectomy more than a decade ago.
Health care workers may be at increased risk of thyroid cancer, study claims Workers exposed to chemicals like deodorizers, sanitizers, disinfectants and sterilizers on the job may be more likely than other people to develop thyroid cancer, a recent study suggests.
Rates of women seeking double-mastectomies for breast cancer vary by state The likelihood that U.S. women with early-stage cancer in one breast will have both breasts removed varies depending on where they live, a new study shows.
Young cancer patients may struggle socially years after diagnosis Child and young adult cancer patients often struggle to lead a normal social life, and even two years after being diagnosed, many still have reduced functioning in the social realm, a recent study suggests.
First responders raise $20G for officer diagnosed with stage 3 cancer after on-duty crash A group of local first responders in Texas is rallying around a police officer who was diagnosed with stage 3 thyroid cancer after she was injured in an on-duty crash in 2016.
Toddler who lost eye in cancer battle gets special look-alike doll A brave little girl who battled cancer received an extra-special gift for her third birthday, thanks to a creative stranger from Idaho.
Novartis says US regulator grants speedy review of CAR-T cell therapy Novartis AG on Wednesday said the U.S. Food and Drug Administration (FDA) has agreed to accelerate its review of the Swiss drugmaker's CTL019 therapy for young patients with B-cell acute lymphoblastic leukemia.
